Griffith Donald J. Insider Trades

Insider Trading History

Track insider trading activity for Griffith Donald J.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Dec 02, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$13.1k 10,375 shares
$1.26
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Chief Financial Officer
Holding Value $13.1k 10,375 shares
Last Trade
Jul 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$51.7k 10,000 shares
$5.17
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Director
Holding Value $473 375 shares
Last Trade
Dec 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.67k 317 shares
$11.59
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Director
Holding Value $13k 10,301 shares
Last Trade
Feb 06, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$92.6k 497 shares
$186.37
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Director
Holding Value $13.6k 10,798 shares
Last Trade
Dec 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$576k 3,214 shares
$179.34
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Director
Holding Value $134k 106,186 shares
Last Trade
Apr 08, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.1M 4,507 shares
$910.52
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Director
Holding Value $139k 110,693 shares
Last Trade
Dec 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.6M 15,000 shares
$1,239.38
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Director
Holding Value $121k 95,693 shares
Last Trade
May 25, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15.7M 4,235 shares
$3,716.92
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Director
Holding Value $126k 99,928 shares
Last Trade
Jul 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179M 20,000 shares
$8,935.38
$1.26
Sonnet BioTherapeutics Holdings
Sonnet BioTherapeutics Holdings SONN
Director
Holding Value $101k 79,928 shares
Last Trade
Apr 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.72B 79,928 shares
$21,552.80
$1.26
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Director
Holding Value $4.35k 144,926 shares
Last Trade
Nov 23, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$0.35 1 shares
$0.35
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
Director
Holding Value $115k 144,926 shares
Last Trade
Nov 23, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.75 1 shares
$3.75
$0.79
Outlook Therapeutics
Outlook Therapeutics OTLK
Director
Holding Value $115k 144,927 shares
Last Trade
Nov 09, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$587k 144,927 shares
$4.05
$0.79
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Director
Holding Value $4.35k 144,927 shares
Last Trade
Nov 09, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$62k 144,927 shares
$0.43
$0.03
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Director
Holding Value $0 0 shares
Last Trade
Nov 09, 2016 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$62k 144,927 shares
$0.43
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
Director
Holding Value $0 0 shares
Last Trade
Nov 09, 2016 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$587k 144,927 shares
$4.05
$0.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up